United States · FDA National Drug Code directory
Xyzal
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 41167-5804_87a83f00-5abf-437d-af13-394c22964050
- Product NDC
- 41167-5804
- Form
- SOLUTION
- Composition / generic term
- levocetirizine dihydrochloride
- Labeler
- Chattem, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20170724
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVOCETIRIZINE DIHYDROCHLORIDE — .5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (41167-5804-5) / 148 mL in 1 BOTTLE · 41167-5804-5
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →